These results indicate that although acetylated androstano-arylpyrimidines might induce a slight elevation in the transcription of some ABC transporters, they do not modulate the drug resistance features of MDR Colo 320 cancer cells by altering the protein expression of ABC transporters. Here, ABCG2 is linked to cancer.